Market research
MPH.AU Mediland Pharm Limited
AU AUD Specialty Retail
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 19M
- P/E ratio
- Not available
- Analyst target
- Not available
- Beta
- Not available
Community
Investor discussion
1 comment
Sign in to join the MPH.AU discussion.
5 years, 5 months ago
Mediland Pharm Limited is currently in a long term downtrend where the price is trading 10.5% below its 200 day moving average.
From a valuation standpoint, the stock is 49.9% cheaper than other stocks from the Consumer Defensive sector with a price to sales ratio of 3.4.
Mediland Pharm Limited's total revenue sank by 96.3% to $727K since the same quarter in the previous year.
Its net income has dropped by 593.1% to $-6M since the same quarter in the previous year.
Finally, its free cash flow grew by 75.0% to $-536K since the same quarter in the previous year.
Based on the above factors, Mediland Pharm Limited gets an overall score of 2/5.